Mechanistic description
Targeted delivery of IGFBPL1 or its functional mimetics could serve as a master switch to restore microglial homeostasis in preclinical AD. This approach would leverage IGFBPL1’s dual role in maintaining surveillance state and resolving existing neuroinflammation before tau pathology spreads.
Debate provenance: derived from debate sess_SDA-2026-04-04-gap-20260404-microglial-priming-early-ad on question: Investigate mechanistic links between early microglial priming states, neuroinflammatory signaling, and downstream neurodegeneration in preclinical and prodromal AD.. Consensus signal: skeptic, synthesizer, theorist discussed the mechanism terms Homeostasis, IGFBPL1, IGFBPL1-Mediated, Microglial, Reset, microglial, neuroinflammation. Novelty signal: skeptic-discussed-with-qualified-concession.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). IGFBPL1-Mediated Microglial Homeostasis Reset Therapy. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-ffb8f8a629e2
@misc{scidex_hypothesis_hdebatef,
title = {IGFBPL1-Mediated Microglial Homeostasis Reset Therapy},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-ffb8f8a629e2},
note = {SciDEX artifact hypothesis:h-debate-ffb8f8a629e2}
}